Ternary Therapeutics

📍 London, United Kingdom🗓 Founded 2024👥 15 employees💰 Last funded Jan 2026
Biotechnology Research🌐 ternarytx.co.uk
Website LinkedIn
TernaryTx, a pioneering biotech startup, with a revolutionary AI-driven platform for designing molecular glue therapeutics, opening new frontiers in drug discovery for previously "undruggable" targets.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
1
France
1
Frequently asked questions
Who invested in Ternary Therapeutics?
Ternary Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Ternary Therapeutics last raise funding?
The most recent investment in Ternary Therapeutics recorded on gritt.io was in January 2026.
When was Ternary Therapeutics founded?
Ternary Therapeutics was founded in 2024.
What industry is Ternary Therapeutics in?
Ternary Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Ternary Therapeutics based?
Ternary Therapeutics is headquartered in London, United Kingdom.